HLB Genex to Participate in "Vitafoods Asia 2026" ... Showcasing SODIZYME

HLB Genex will participate in "Vitafoods Asia 2026," which will be held from September 2 to 4 at the Queen Sirikit National Convention Center in Bangkok, Thailand.

According to HLB Genex on August 25, Vitafoods Asia is a global B2B exhibition featuring companies from the Asia-Pacific region involved in health functional foods, functional beverages, and health supplements. This year, the exhibition is themed "Nutrition for Healthy Living and Longevity," showcasing functional ingredients, technologies, and products related to healthy aging.

HLB Genex will highlight its enzyme ingredient brand, SODIZYME. SODIZYME is the company's flagship brand based on the powerful antioxidant enzyme SOD (Superoxide Dismutase), which has already been supplied to customers in Southeast Asia, including Thailand. SODIZYME is a core ingredient brand for HLB Genex, distinguished by its proprietary ingredient manufacturing capability and key patented technologies. It is based on Korea's first naturally derived SOD enzyme from microorganisms.

Through the operation of its exhibition booth, the company aims to promote the excellence of SODIZYME as a functional ingredient and further strengthen its business foundation in rapidly growing Southeast Asian markets such as Vietnam and Indonesia. In particular, HLB Genex plans to actively identify new business partners during the exhibition and expand collaboration with major global partners to intensify its efforts in global market expansion.

During the exhibition, HLB Genex will participate in major sessions and conferences to review the latest technology trends in the global healthcare market, such as functional ingredients, inner beauty, and artificial intelligence (AI)-based product development. The company will closely monitor regulatory changes and market demand for health functional foods in major Asian countries and utilize this knowledge for developing new ingredients and products and for country-specific, tailored research and development (R&D) in the future.

A representative from HLB Genex said, "Vitafoods Asia 2026 will be an opportunity to showcase the technological competitiveness of SODIZYME to the global market and materialize the overseas expansion of functional enzyme ingredients. Based on our enzyme development and manufacturing capabilities, we will expand our product portfolio and translate this into tangible business results in the global marketplace."

This content was produced with the assistance of AI translation services.